1 - 25 of 50 results for author:"Binder B.R." in Literature citations
Results Customize
› Repeat search in UniProtKB (17)
| The urokinase receptor (CD87) represents a central mediator of growth factor-induced endothelial cell migration. Poettler M., Unseld M., Mihaly-Bison J., Uhrin P., Koban F., Binder B.R., Zielinski C.C., Prager G.W. Thromb. Haemost. 108:357-366(2012) · Mapped (3) |
| The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors. Papac-Milicevic N., Breuss J.M., Zaujec J., Ryban L., Plyushch T., Wagner G.A., Fenzl S., Dremsek P., Cabaravdic M., Steiner M. et al. Circ. Res. 110:e50-63(2012) · Mapped (10) |
| VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution. Alexander R.A., Prager G.W., Mihaly-Bison J., Uhrin P., Sunzenauer S., Binder B.R., Schutz G.J., Freissmuth M., Breuss J.M. Cardiovasc. Res. 94:125-135(2012) · Mapped (16) |
| Constant darkness induces IL-6-dependent depression-like behavior through the NF-kappaB signaling pathway. Monje F.J., Cabatic M., Divisch I., Kim E.J., Herkner K.R., Binder B.R., Pollak D.D. J. Neurosci. 31:9075-9083(2011) · Mapped (6) |
| Signal integration and coincidence detection in the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) cascade: concomitant activation of receptor tyrosine kinases and of LRP-1 leads to sustained ERK phosphorylation via down-regulation of dual specificity phosphatases (DUSP1 and -6). Geetha N., Mihaly J., Stockenhuber A., Blasi F., Uhrin P., Binder B.R., Freissmuth M., Breuss J.M. J. Biol. Chem. 286:25663-25674(2011) · Mapped (30) |
| Density enhanced phosphatase-1 down-regulates urokinase receptor surface expression in confluent endothelial cells. Brunner P.M., Heier P.C., Mihaly-Bison J., Priglinger U., Binder B.R., Prager G.W. Blood 117:4154-4161(2011) · Mapped (5) |
| Soluble M6P/IGF2R released by TACE controls angiogenesis via blocking plasminogen activation. Leksa V., Loewe R., Binder B., Schiller H.B., Eckerstorfer P., Forster F., Soler-Cardona A., Ondrovicova G., Kutejova E., Steinhuber E. et al. Circ. Res. 108:676-685(2011) · Mapped (27) |
| Anti-inflammatory properties of the PI3K pathway are mediated by IL-10/DUSP regulation. Gunzl P., Bauer K., Hainzl E., Matt U., Dillinger B., Mahr B., Knapp S., Binder B.R., Schabbauer G. J. Leukoc. Biol. 88:1259-1269(2010) · Mapped (11) |
| Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo. Schwaiberger A.V., Heiss E.H., Cabaravdic M., Oberan T., Zaujec J., Schachner D., Uhrin P., Atanasov A.G., Breuss J.M., Binder B.R. et al. Arterioscler. Thromb. Vasc. Biol. 30:2475-2481(2010) · Mapped (7) |
| Myeloid PTEN promotes inflammation but impairs bactericidal activities during murine pneumococcal pneumonia. Schabbauer G., Matt U., Gunzl P., Warszawska J., Furtner T., Hainzl E., Elbau I., Mesteri I., Doninger B., Binder B.R. et al. J. Immunol. 185:468-476(2010) · Mapped (16) |
| Oxidized phospholipids regulate expression of ATF4 and VEGF in endothelial cells via NRF2-dependent mechanism: novel point of convergence between electrophilic and unfolded protein stress pathways. Afonyushkin T., Oskolkova O.V., Philippova M., Resink T.J., Erne P., Binder B.R., Bochkov V.N. Arterioscler. Thromb. Vasc. Biol. 30:1007-1013(2010) · Mapped (18) |
| Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Uhrin P., Zaujec J., Breuss J.M., Olcaydu D., Chrenek P., Stockinger H., Fuertbauer E., Moser M., Haiko P., Fassler R. et al. Blood 115:3997-4005(2010) · Mapped (14) |
| Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab. Prager G.W., Lackner E.M., Krauth M.T., Unseld M., Poettler M., Laffer S., Cerny-Reiterer S., Lamm W., Kornek G.V., Binder B.R. et al. Mol Oncol 4:150-160(2010) · Mapped (7) |
| Crosstalk between the NF-kappaB activating IKK-complex and the CSN signalosome. Orel L., Neumeier H., Hochrainer K., Binder B.R., Schmid J.A. J. Cell. Mol. Med. 14:1555-1568(2010) · Mapped (1) |
| Podoplanin deficient mice show a RhoA-related hypoplasia of the sinus venosus myocardium including the sinoatrial node. Mahtab E.A., Vicente-Steijn R., Hahurij N.D., Jongbloed M.R., Wisse L.J., DeRuiter M.C., Uhrin P., Zaujec J., Binder B.R., Schalij M.J. et al. Dev. Dyn. 238:183-193(2009) · Mapped (21) |
| Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor. Schiller H.B., Szekeres A., Binder B.R., Stockinger H., Leksa V. Mol. Biol. Cell 20:745-756(2009) · Mapped (15) |
| Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein. Prager G.W., Mihaly J., Brunner P.M., Koshelnick Y., Hoyer-Hansen G., Binder B.R. Blood 113:1383-1390(2009) · Mapped (3) |
| Pulmonary vein, dorsal atrial wall and atrial septum abnormalities in podoplanin knockout mice with disturbed posterior heart field contribution. Douglas Y.L., Mahtab E.A., Jongbloed M.R., Uhrin P., Zaujec J., Binder B.R., Schalij M.J., Poelmann R.E., Deruiter M.C., Gittenberger-de Groot A.C. Pediatr. Res. 65:27-32(2009) · Mapped (9) |
| Highly homologous HERC proteins localize to endosomes and exhibit specific interactions with hPLIC and Nm23B. Hochrainer K., Kroismayr R., Baranyi U., Binder B.R., Lipp J. Cell. Mol. Life Sci. 65:2105-2117(2008) · Mapped (2) |
| ATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response. Oskolkova O.V., Afonyushkin T., Leitner A., von Schlieffen E., Gargalovic P.S., Lusis A.J., Binder B.R., Bochkov V.N. Blood 112:330-339(2008) · Mapped (11) |
| Cardiac malformations and myocardial abnormalities in podoplanin knockout mouse embryos: Correlation with abnormal epicardial development. Mahtab E.A., Wijffels M.C., Van Den Akker N.M., Hahurij N.D., Lie-Venema H., Wisse L.J., Deruiter M.C., Uhrin P., Zaujec J., Binder B.R. et al. Dev. Dyn. 237:847-857(2008) · Mapped (19) |
| Nuclear factor of activated T cells and early growth response-1 cooperate to mediate tissue factor gene induction by vascular endothelial growth factor in endothelial cells. Schabbauer G., Schweighofer B., Mechtcheriakova D., Lucerna M., Binder B.R., Hofer E. Thromb. Haemost. 97:988-997(2007) · Mapped (5) |
| Male fertility and protein C inhibitor/plasminogen activator inhibitor-3 (PCI): localization of PCI in mouse testis and failure of single plasminogen activator knockout to restore spermatogenesis in PCI-deficient mice. Uhrin P., Schofer C., Zaujec J., Ryban L., Hilpert M., Weipoltshammer K., Jerabek I., Pirtzkall I., Furtmuller M., Dewerchin M. et al. Fertil. Steril. 88:1049-1057(2007) · Mapped (6) |
| Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Kronke G., Kadl A., Ikonomu E., Bluml S., Furnkranz A., Sarembock I.J., Bochkov V.N., Exner M., Binder B.R., Leitinger N. Arterioscler. Thromb. Vasc. Biol. 27:1276-1282(2007) · Mapped (6) |
| Regulation of protein C inhibitor (PCI) activity by specific oxidized and negatively charged phospholipids. Malleier J.M., Oskolkova O., Bochkov V., Jerabek I., Sokolikova B., Perkmann T., Breuss J., Binder B.R., Geiger M. Blood 109:4769-4776(2007) · Mapped (4) |